Viz.ai

San Francisco, United States Founded: 2016 • Age: 10 yrs Unicorn
AI and cloud-powered software for stroke care coordination is developed.

About Viz.ai

Viz.ai is a Healthcare company based in San Francisco (United States) founded in 2016 by Chris Mansi and David Golan. AI and cloud-powered software for stroke care coordination is developed. It operates in the Healthcare and Technology sectors. Viz.ai has raised $251.99 million across 7 funding rounds from investors including Canadian Imperial Bank of Commerce, Kleiner Perkins and Seedcamp. The company has 326 employees. Viz.ai was last valued at $1.2 billion in January 2026. Its chief executive, as recorded, is Chris Mansi. Its website viz.ai draws about 82 thousand monthly visits. Viz.ai offers products and services including Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite. Its focus areas include High Tech, Image Recognition, Applications and Diagnosis. Its competitors include AIdoc, PathAI and Deepcell; 3 of its 3 listed competitors have raised funding.

Company details

Viz.ai was founded in 2016 in San Francisco, United States, within the healthcare technology sector. AI-driven care coordination software is provided for stroke diagnosis and neurology support. Emergency medical cases are addressed through tools that compare patient scans to databases, identifying patterns for conditions. Scans are categorized into types to aid clinical decisions, with operations centered on cloud-based platforms.

  • Headquarters San Francisco, United States
  • Employees 326
  • Founders Chris Mansi, David Golan
  • Stage Unicorn
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website viz.ai
  • Social LinkedIn X Facebook
  • Legal Name Viz.Ai
Key Metrics

Products & Services of Viz.ai

Viz.ai offers a comprehensive portfolio of products and services, including Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite.

Viz.ai One
Care Coordination Platform

AI solution for detecting and coordinating treatments across diseases.

Viz Neuro Suite
Neurovascular Diagnostics

AI tools for identifying strokes and aneurysms in medical imaging.

Viz Vascular Suite
Vascular Disease Detection

Platform for pulmonary embolism and aortic disease analysis.

Viz Cardio Suite
Cardiovascular Tools

AI for hypertrophic cardiomyopathy and post-stroke care.

Viz Radiology Suite
Imaging Analysis

AI to accelerate diagnosis in radiology workflows.

Apps and channels of Viz.ai

Viz.ai publishes 2 mobile apps with over 10K+ downloads.

Viz.ai
Google Play Medical Everyone Free
Developer: Viz.ai, Inc.
View on Google Play
Viz Training AI Stroke Care
App Store Medical 4+
Developer: Viz.ai, Inc.
View on App Store

Funding Insights of Viz.ai

Viz.ai has successfully raised a total of $251.99M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $40 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $251.99M
  • Total Rounds 7
  • Last Round Debt – Conventional β€” $40M
  • First Round $2.49M

    (Sep 2016)

  • Investors Count 19

All 7 funding rounds of Viz.ai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2023$40MDebt – Conventional––
Apr 2022$100MSeries D$1.2BTiger Global Management, Insight Partners
Mar 2021$71MSeries C–Scale Venture Partners, Insight Partners
Oct 2019$50MSeries B–Greenoaks
Jul 2018$21MSeries A–Kleiner Perkins
May 2017$7.5MSeed–Innovation Endeavors, DHVC
Sep 2016$2.49MSeed––
Valuation history
DateValuationStage
Apr 2022$1.2Bβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.2B (Jan 2026). 19 investors in total: 19 institutional.

Investors in Viz.ai

Viz.ai has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, Kleiner Perkins and Seedcamp.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture and private equity investments are managed with global diversification.
tigerglobal.comNew York, United States
Investment firm scaling software and technology companies from early to late stages.
insightpartners.com
Early-stage venture capital investments are focused on US companies.
scalevp.comFoster City, United States
Venture capital firm investing in early-stage tech startups
1972kleinerperkins.comMenlo Park, United States
Early-stage startups are funded by Threshold VC firm.
threshold.vcPalo Alto, United States
CRV is recognized as a venture capital firm investing in technology startups.
crv.comPalo Alto, United States
Corporate backed venture capital fund investing in multiple sectors
gv.comMountain View, United States
Venture capital firm investing in early-stage companies across fintech, healthcare, and multiple sectors
susaventures.comSan Francisco, United States
Seed & early stage VC firm investing the US
2013pear.vcSan Francisco, United States
Venture capital firm focused on multiple sectors
sozoventures.comRedwood City, United States
Premium access

Investor details for Viz.ai

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Viz.ai

77 people are tracked at Viz.ai (32 in leadership, 4 in board & advisors, 41 in team); the tracked headcount is 326.

NameRoleGroup
Chris Mansi
Co-Founder & CEOLeadership
David Golan
Co-FounderLeadership
Prem Batchu-Green
VP, ClinicalLeadership
Steve Sweeny
VP, Business Development & StrategyLeadership
Shelly Yehezkely
VP of AILeadership
Jieun Choe
Chief Operating OfficerLeadership
David Kizner
General Counsel & Chief Privacy OfficerLeadership
Julie Skaff
COOLeadership
Jill Martin
Director Of Sales TrainingLeadership
Kirubel Frew
Vice President Of Business DevelopmentLeadership
Michael Herring
Chief Financial OfficerLeadership
Mike Herring
Chief Financial OfficerLeadership
Dawn Sprague
VP of PeopleLeadership
Bill Stadtlander
VP, Global MedTech Commercial LeadLeadership
Jamie Stern
Senior Director, Clinical Strategy & Care Pathway ProgramsLeadership
Matt Longo
Senior Director, Corporate Development (m&a) And PartnershipsLeadership
Eli Goz
Director Of Artificial IntelligenceLeadership
Matt Baechle
Senior Director, Corporate Strategic AccountsLeadership
Mhrm Liana Rodriguez
Director Of Global People Operations (pops)Leadership
Liron Gazit
Director, Talent Acquisition - EMEALeadership

57 more people are available in the full profile.

Premium access

Complete people profiles for Viz.ai

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Viz.ai

4 dated milestones of Viz.ai across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Viz.ai is founded.
  2. Funding First funding round of $2.5M.
  3. Milestone Reaches Unicorn status.
  4. Funding Latest funding round, Debt – Conventional, of $40.0M.

Competitors of Viz.ai

Viz.ai has 3 listed competitors in our database, 3 of them funded. They include AIdoc, PathAI and Deepcell.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aidoc.com2016New York, United States$424.5M
AI-based single-screen system is provided to streamline medical imaging.
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
deepcell.com2015Mountain View, United States$122.99M94
AI-powered single cell classification and isolation technology for clinical research
Premium access

Detailed competitors of Viz.ai

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Viz.ai

The website of Viz.ai (viz.ai) receives about 81.7K visits a month.

  • Monthly visits
    81.7K

    ▲ 2.6% vs previous month

Similar websites

Websites whose visitors overlap most with Viz.ai. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
vantagemedtech.com
100%
9.4K#2,185,589View details
jorie.ai
100%
680.7K#1,461,670View details
thehealthcaretechnologyreport.com
100%
#1,012,018View details
bms.com
100%
809.8K#67,210View details
notablehealth.com
100%
18.8K#1,445,552View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for Viz.ai

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Viz.ai (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Viz.Ai

Premium access

Complete news archive for Viz.ai

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viz.ai

Viz.ai was founded in 2016.

Viz.ai is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Chris Mansi is the CEO of Viz.ai, as recorded in our data. They have also founded this company.

Viz.ai is a funded company, having raised a total of $251.99M across 7 funding rounds to date. The company's 1st funding round was a Seed of $2.49M, raised on Sep 2016.

Viz.ai has 326 employees.

Viz.ai was founded in 2016 in San Francisco, United States, within the healthcare technology sector. AI-driven care coordination software is provided for stroke diagnosis and neurology support. Emergency medical cases are addressed through tools that compare patient scans to databases, identifying patterns for conditions. Scans are categorized into types to aid clinical decisions, with operations centered on cloud-based platforms.

Viz.ai's top competitors include AIdoc, PathAI and Deepcell.

Viz.ai offers Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite.

Viz.ai has 19 investors. Key investors include Canadian Imperial Bank of Commerce, Kleiner Perkins, Seedcamp, Pear VC, and Tiger Global.

The valuation of Viz.ai is $1.2B as of Jan 2026.

Viz.ai operates through Viz.Ai.

Yes. Viz.ai publishes Viz.ai and 1 more app, with over 10,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available